The regulation of foxP3-expressing regulatory T cells

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 11, Issue 4, 2011, Pages 334-346

  Haque, Rizwanul ^a   Lei, Fengyang ^a   Xiong, Xiaofang ^a   Song, Jianxun ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cell differentiation; FoxP3; Immune regulation; Regulatory T cells; Signal transduction

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; AUTOIMMUNE DISEASE; CELL CONTACT; CELL TYPE; GENE EXPRESSION REGULATION; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATORY DISEASE; LYMPHOCYTE DIFFERENTIATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

EID: 80055121697     PISSN: 18715303     EISSN: 18715303     Source Type: Journal    
DOI: 10.2174/187153011797881157     Document Type: Article

References (151)

1. Ling, Y.; Cao, X.; Yu, Z. and Ruan, C. (2007) Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur. J. Haematol., 79(4), 310-316.
2. Ahmadzadeh, M.; Antony, P. A. and Rosenberg, S. A. (2007) IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cells. J. Immunother., 30(3), 294-302.
3. Hori, S.; Nomura, T. and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science, 299(5609), 1057-1061.
4. Haque, R.; Lei, F.; Xiong, X.; Wu, Y. and Song, J. (2010) FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development. Arthritis Res. Ther., 12(2), R66.
5. Godfrey, V. L.; Wilkinson, J. E. and Russell, L. B. (1991) X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol., 138(6), 1379-1387.
6. Blair, P. J.; Bultman, S. J.; Haas, J. C.; Rouse, B. T.; Wilkinson, J. E. and Godfrey, V. L. (1994) CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol., 153(8), 3764-3774.
7. Brunkow, M. E.; Jeffery, E. W.; Hjerrild, K. A.; Paeper, B.; Clark, L. B.; Yasayko, S. A.; Wilkinson, J. E.; Galas, D.; Ziegler, S. F. and Ramsdell, F. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet., 27(1), 68-73.
8. Ochs, H. D.; Ziegler, S. F. and Torgerson, T. R. (2005) FOXP3 acts as a rheostat of the immune response. Immunol. Rev., 203, 156-164.
9. Miyara, M.; Wing, K. and Sakaguchi, S. (2009) Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. J. Allergy Clin. Immunol., 123(4), 749-755; quiz 756-7.
10. Pandiyan, P. and Lenardo, M. J. (2008) The control of CD4+CD25+Foxp3+ regulatory T cell survival. Biol. Direct., 3, 6.
11. Pandiyan, P.; Zheng, L.; Ishihara, S.; Reed, J. and Lenardo, M. J. (2007) CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol., 8(12), 1353-1362.
12. Taams, L. S.; Smith, J.; Rustin, M. H.; Salmon, M.; Poulter, L. W. and Akbar, A. N. (2001) Human anergic/suppressive CD4(+) CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol., 31(4), 1122-1131.
13. Ding, Y.; Shen, S.; Lino, A. C.; Curotto de Lafaille, M. A. and Lafaille, J. J. (2008) Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells. Nat. Med., 14(2), 162-169.
14. Sharabi, A.; Lapter, S. and Mozes, E. (2010) Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide. J. Autoimmun., 34(2), 87-95.
15. Kang, H. J.; Song, M. J.; Choung, S. Y.; Kim, S. J. and Le, M. O. (2000) Transcriptional induction of Nur77 by indomethacin that results in apoptosis of colon cancer cells. Biol. Pharm. Bull., 23(7), 815-819.
16. Toth, R.; Szegezdi, E.; Reichert, U.; Bernardon, J. M.; Michel, S.; Ancian, P.; Kis-Toth, K.; Macsari, Z.; Fesus, L. and Szondy, Z. (2001) Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells. Eur. J. Immunol., 31(5), 1382-1391.
17. Fritzsching, E.; Kunz, P.; Maurer, B.; Poschl, J. and Fritzsching, B. (2009) Regulatory T cells and tolerance induction. Clin. Transplant., 23(Suppl 21), 10-4.
18. Cederbom, L.; Hall, H. and Ivars, F. (2000) CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol., 30(6), 1538-1543.
19. Piccirillo, C. A. and Shevach, E. M. (2001) Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol., 167(3), 1137-1140.
20. Misra, N.; Bayry, J.; Lacroix-Desmazes, S.; Kazatchkine, M. D. and Kaveri, S. V. (2004) Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol., 172(8), 4676-4680.
21. Ghiringhelli, F.; Menard, C.; Terme, M.; Flament, C.; Taieb, J.; Chaput, N.; Puig, P. E.; Novault, S.; Escudier, B.; Vivier, E.; Lecesne, A.; Robert, C.; Blay, J. Y.; Bernard, J.; Caillat-Zucman, S.; Freitas, A.; Tursz, T.; Wagner-Ballon, O.; Capron, C.; Vainchencker, W.; Martin, F. and Zitvogel, L. (2005) CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med., 202(8), 1075-1085.
22. Lim, H. W.; Hillsamer, P.; Banham, A. H. and Kim, C. H. (2005) Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol., 175(7), 4180-4183.
23. Taams, L. S.; van Amelsfort, J. M.; Tiemessen, M. M.; Jacobs, K. M.; de Jong, E. C.; Akbar, A. N.; Bijlsma, J. W. and Lafeber, F. P. (2005) Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum. Immunol., 66(3), 222-230.
24. Jang, E.; Cho, W. S.; Cho, M. L.; Park, H. J.; Oh, H. J.; Kang, S. M.; Paik, D. J. and Youn, J. (2011) Foxp3+ regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells. J. Immunol., 186(3), 1546-1553.
25. Malek, T. R. (2003) The main function of IL-2 is to promote the development of T regulatory cells. J. Leukoc. Biol., 74(6), 961-965.
26. Zorn, E.; Nelson, E. A.; Mohseni, M.; Porcheray, F.; Kim, H.; Litsa, D.; Bellucci, R.; Raderschall, E.; Canning, C.; Soiffer, R. J.; Frank, D. A. and Ritz, J. (2006) IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood, 108(5), 1571-1579.
27. Furtado, G. C.; Curotto de Lafaille, M. A.; Kutchukhidze, N. and Lafaille, J. J. (2002) Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med., 196(6), 851-857.
28. Suzuki, T.; Hiromatsu, K.; Ando, Y.; Okamoto, T.; Tomoda, Y. and Yoshikai, Y. (1995) Regulatory role of gamma delta T cells in uterine intraepithelial lymphocytes in maternal antifetal immune response. J. Immunol., 154(9), 4476-4484.
29. Willerford, D. M.; Chen, J.; Ferry, J. A.; Davidson, L.; Ma, A. and Alt, F. W. (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity, 3(4), 521-530.
30. Kramer, S.; Schimpl, A. and Hunig, T. (1995) Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J. Exp. Med., 182(6), 1769-76.
31. Schimpl, A.; Berberich, I.; Kneitz, B.; Kramer, S.; Santner-Nanan, B.; Wagner, S.; Wolf, M. and Hunig, T. (2002) IL-2 and autoimmune disease. Cytokine Growth Factor Rev., 13(4-5), 369-378.
32. Bachmann, M. F. and Oxenius, A. (2007) Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep., 8(12), 1142-1148.
33. Papiernik, M.; de Moraes, M. L.; Pontoux, C.; Vasseur, F. and Penit, C. (1998) Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol., 10(4), 371-378.
34. Wolf, M.; Schimpl, A. and Hunig, T. (2001) Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol., 31(6), 1637-1645.
35. Malek, T. R.; Yu, A.; Vincek, V.; Scibelli, P. and Kong, L. (2002) CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity, 17(2), 167-178.
36. Almeida, A. R.; Legrand, N.; Papiernik, M. and Freitas, A. A. (2002) Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol., 169(9), 4850-4860.
37. Murakami, M.; Sakamoto, A.; Bender, J.; Kappler, J. and Marrack, P. (2002) CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl. Acad. Sci. USA, 99(13), 8832-8837.
38. Thornton, A. M. and Shevach, E. M. (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med., 188(2), 287-296.
39. Takahashi, T.; Kuniyasu, Y.; Toda, M.; Sakaguchi, N.; Itoh, M.; Iwata, M.; Shimizu, J. and Sakaguchi, S. (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol., 10(12), 1969-1980.
40. Oberle, N.; Eberhardt, N.; Falk, C. S.; Krammer, P. H. and Suri-Payer, E. (2007) Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. J. Immunol., 179(6), 3578-3587.
41. Zheng, S. G.; Wang, J.; Wang, P.; Gray, J. D. and Horwitz, D. A. (2007) IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol., 2007, 178, (4), 2018-2027.
42. Wu, Y.; Borde, M.; Heissmeyer, V.; Feuerer, M.; Lapan, A. D.; Stroud, J. C.; Bates, D. L.; Guo, L.; Han, A.; Ziegler, S. F.; Mathis, D.; Benoist, C.; Chen, L. and Rao, A. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell, 126(2), 375-387.
43. Ono, M.; Yaguchi, H.; Ohkura, N.; Kitabayashi, I.; Nagamura, Y.; Nomura, T.; Miyachi, Y.; Tsukada, T. and Sakaguchi, S. (2007) Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature, 446(7136), 685-689.
44. Marson, A.; Kretschmer, K.; Frampton, G. M.; Jacobsen, E. S.; Polansky, J. K.; MacIsaac, K. D.; Levine, S. S.; Fraenkel, E.; von Boehmer, H. and Young, R. A. (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature, 445(7130), 931-935.
45. Shevach, E. M. (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity, 30(5), 636-645.
46. Kretschmer, K.; Apostolou, I.; Hawiger, D.; Khazaie, K.; Nussenzweig, M. C. and von Boehmer, H. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol., 6(12), 1219-27.
47. Chen, W.; Jin, W.; Hardegen, N.; Lei, K. J.; Li, L.; Marinos, N.; McGrady, G. and Wahl, S. M. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med., 198(12), 1875-1886.
48. Liu, H. and Leung, B. P. (2006) CD4+CD25+ regulatory T cells in health and disease. Clin. Exp. Pharmacol. Physiol., 33(5-6), 519-524.
49. Floess, S.; Freyer, J.; Siewert, C.; Baron, U.; Olek, S.; Polansky, J.; Schlawe, K.; Chang, H. D.; Bopp, T.; Schmitt, E.; Klein-Hessling, S.; Serfling, E.; Hamann, A. and Huehn, J. (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol., 5(2), e38.
50. Tone, Y.; Furuuchi, K.; Kojima, Y.; Tykocinski, M. L.; Greene, M. I. and Tone, M. (2008) Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol., 9(2), 194-202.
51. Takimoto, T.; Wakabayashi, Y.; Sekiya, T.; Inoue, N.; Morita, R.; Ichiyama, K.; Takahashi, R.; Asakawa, M.; Muto, G.; Mori, T.; Hasegawa, E.; Saika, S.; Hara, T.; Nomura, M. and Yoshimura, A. (2010) Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J. Immunol., 185(2), 842-855.
52. Ouyang, W.; Beckett, O.; Ma, Q. and Li, M. O. (2010) Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity, 32(5), 642-653.
53. Chougnet, C. A.; Tripathi, P.; Lages, C. S.; Raynor, J.; Sholl, A.; Fink, P.; Plas, D. R. and Hildeman, D. A. (2010) A major role for Bim in regulatory T cell homeostasis. J. Immunol., 186(1), 156-163.
54. Liu, Y.; Zhang, P.; Li, J.; Kulkarni, A. B.; Perruche, S. and Chen, W. (2008) A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat. Immunol., 9(6), 632-640.
55. Collison, L. W.; Workman, C. J.; Kuo, T. T.; Boyd, K.; Wang, Y.; Vignali, K. M.; Cross, R.; Sehy, D.; Blumberg, R. S. and Vignali, D. A. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450(7169), 566-569.
56. Castellani, M. L.; Anogeianaki, A.; Felaco, P.; Toniato, E.; De Lutiis, M. A.; Shaik, B.; Fulcheri, M.; Vecchiet, J.; Tete, S.; Salini, V.; Theoharides, T. C.; Caraffa, A.; Antinolfi, P.; Frydas, I.; Conti, P.; Cuccurullo, C.; Ciampoli, C.; Cerulli, G. and Kempuraj, D. (2010) IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells. J. Biol. Regul. Homeost. Agents, 24(2), 131-135.
57. Niedbala, W.; Wei, X. Q.; Cai, B.; Hueber, A. J.; Leung, B. P.; McInnes, I. B. and Liew, F. Y. (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol., 37(11), 3021-3029.
58. Robinson, D. S. (2009) Regulatory T cells and asthma. Clin. Exp. Allergy, 39(9), 1314-1323.
59. Wu, J.; Yi, S.; Ouyang, L.; Jimenez, E.; Simond, D.; Wang, W.; Wang, Y.; Hawthorne, W. J. and O'Connell, P. J. (2008) In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation, 85(12), 1841-1848.
60. Bardel, E.; Larousserie, F.; Charlot-Rabiega, P.; Coulomb-L'Hermine, A. and Devergne, O. (2008) Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J. Immunol., 181(10), 6898-6905.
61. Allan, S. E.; Song-Zhao, G. X.; Abraham, T.; McMurchy, A. N. and Levings, M. K. (2008) Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur. J. Immunol., 38(12), 3282-3289.
62. Collison, L. W.; Chaturvedi, V.; Henderson, A. L.; Giacomin, P. R.; Guy, C.; Bankoti, J.; Finkelstein, D.; Forbes, K.; Workman, C. J.; Brown, S. A.; Rehg, J. E.; Jones, M. L.; Ni, H. T.; Artis, D.; Turk, M. J. and Vignali, D. A. (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol., 11(12), 1093-1101.
63. Ilarregui, J. M.; Croci, D. O.; Bianco, G. A.; Toscano, M. A.; Salatino, M.; Vermeulen, M. E.; Geffner, J. R. and Rabinovich, G. A. (2009) Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol., 10(9), 981-991.
64. Rabinovich, G. A.; Ramhorst, R. E.; Rubinstein, N.; Corigliano, A.; Daroqui, M. C.; Kier-Joffe, E. B. and Fainboim, L. (2002) Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms. Cell Death Differ, 9(6), 661-670.
65. Garin, M. I.; Chu, C. C.; Golshayan, D.; Cernuda-Morollon, E.; Wait, R. and Lechler, R. I. (2007) Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood, 109(5), 2058-2065.
66. Liu, S. D.; Lee, S.; La Cava, A.; Motran, C. C.; Hahn, B. H. and Miceli, M. C. (2011) Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupuslike disease. Lupus, Feb 18. [Epub ahead of print]
67. Kubach, J.; Lutter, P.; Bopp, T.; Stoll, S.; Becker, C.; Huter, E.; Richter, C.; Weingarten, P.; Warger, T.; Knop, J.; Mullner, S.; Wijdenes, J.; Schild, H.; Schmitt, E. and Jonuleit, H. (2007) Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood, 110(5), 1550-1558.
68. Tivol, E. A.; Borriello, F.; Schweitzer, A. N.; Lynch, W. P.; Bluestone, J. A. and Sharpe, A. H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity, 3(5), 541-547.
69. Waterhouse, P.; Penninger, J. M.; Timms, E.; Wakeham, A.; Shahinian, A.; Lee, K. P.; Thompson, C. B.; Griesser, H. and Mak, T. W. (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science, 270(5238), 985-988.
70. Zheng, Y.; Manzotti, C. N.; Burke, F.; Dussably, L.; Qureshi, O.; Walker, L. S.; Sansom, D. M. (2008) Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol., 181(3), 1683-1691.
71. Kolar, P.; Knieke, K.; Hegel, J. K.; Quandt, D.; Burmester, G. R.; Hoff, H. and Brunner-Weinzierl, M. C. (2009) CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum., 60(1), 123-132.
72. Thompson, C. B. and Allison, J.P. (1997) The emerging role of CTLA-4 as an immune attenuator. Immunity, 7(4), 445-450.
73. Sojka, D. K.; Hughson, A. and Fowell, D. J. (2009) CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation. Eur. J. Immunol., 39(6), 1544-1551.
74. Wing, K.; Onishi, Y.; Prieto-Martin, P.; Yamaguchi, T.; Miyara, M.; Fehervari, Z.; Nomura, T. and Sakaguchi, S. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science, 322(5899), 271-275.
75. Verhasselt, V.; Vosters, O.; Beuneu, C.; Nicaise, C.; Stordeur, P. and Goldman, M. (2004) Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur. J. Immunol., 34(3), 762-772.
76. Moseman, E. A.; Liang, X.; Dawson, A. J.; Panoskaltsis-Mortari, A.; Krieg, A. M.; Liu, Y. J.; Blazar, B. R. and Chen, W. (2004) Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol., 173(7), 4433-4442.
77. Verginis, P.; Li, H. S. and Carayanniotis, G. (2005) Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J. Immunol., 174(11), 7433-7439.
78. Castellaneta, A.; Mazariegos, G. V.; Nayyar, N.; Zeevi, A. and Thomson, A. W. (2011) HLA-G Level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance. Transplantation, Mar 17. [Epub ahead of print].
79. Ghiringhelli, F.; Puig, P. E.; Roux, S.; Parcellier, A.; Schmitt, E.; Solary, E.; Kroemer, G.; Martin, F.; Chauffert, B. and Zitvogel, L. (2005) Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med., 202(7), 919-929.
80. Ochando, J. C.; Homma, C.; Yang, Y.; Hidalgo, A.; Garin, A.; Tacke, F.; Angeli, V.; Li, Y.; Boros, P.; Ding, Y.; Jessberger, R.; Trinchieri, G.; Lira, S. A.; Randolph, G. J. and Bromberg, J. S. (2006) Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol., 7(6), 652-662.
81. Ito, T.; Yang, M.; Wang, Y. H.; Lande, R.; Gregorio, J.; Perng, O. A.; Qin, X. F.; Liu, Y. J. and Gilliet, M. (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med., 204(1), 105-115.
82. Jongbloed, S. L.; Benson, R. A.; Nickdel, M. B.; Garside, P.; McInnes, I. B. and Brewer, J. M. (2009) Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis. J. Immunol., 182(2), 963-968.
83. Kavousanaki, M.; Makrigiannakis, A.; Boumpas, D. and Verginis, P. (2010) Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy. Arthritis Rheum., 62(1), 53-63.
84. Watanabe, N.; Wang, Y. H.; Lee, H. K.; Ito, T.; Cao, W. and Liu, Y. J. (2005) Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature, 436(7054), 1181-1185.
85. Liu, Y. J.; Soumelis, V.; Watanabe, N.; Ito, T.; Wang, Y. H.; Malefyt Rde, W.; Omori, M.; Zhou, B. and Ziegler, S. F. (2007) TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol., 25, 193-219.
86. Yamazaki, S.; Iyoda, T.; Tarbell, K.; Olson, K.; Velinzon, K.; Inaba, K. and Steinman, R. M. (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med., 198(2), 235-247.
87. Tarbell, K. V.; Yamazaki, S.; Olson, K.; Toy, P. and Steinman, R. M. (2004) CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med., 199(11), 1467-1477.
88. Yamazaki, S.; Inaba, K.; Tarbell, K. V. and Steinman, R. M. (2006) Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol. Rev., 212, 314-329.
89. Darrasse-Jeze, G.; Deroubaix, S.; Mouquet, H.; Victora, G. D.; Eisenreich, T.; Yao, K. H.; Masilamani, R. F.; Dustin, M. L.; Rudensky, A.; Liu, K. and Nussenzweig, M.C. (2009) Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med., 206(9), 1853-1862.
90. Smith, T. R.; Maricic, I.; Ria, F.; Schneider, S. and Kumar, V. (2010) CD8alpha+ dendritic cells prime TCR-peptide-reactive regulatory CD4+FOXP3- T cells. Eur. J. Immunol., 40(7), 1906-1915.
91. Malek, T. R.; Yu, A.; Zhu, L.; Matsutani, T.; Adeegbe, D. and Bayer, A. L. (2008) IL-2 family of cytokines in T regulatory cell development and homeostasis. J. Clin. Immunol., 28(6), 635-639.
92. Salomon, B.; Lenschow, D. J.; Rhee, L.; Ashourian, N.; Singh, B.; Sharpe, A. and Bluestone, J.A. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immuno-regulatory T cells that control autoimmune diabetes. Immunity, 12(4), 431-40.
93. Sakaguchi, S.; Yamaguchi, T.; Nomura, T. and Ono, M. (2008) Regulatory T cells and immune tolerance. Cell, 133(5), 775-787.
94. Picca, C. C.; Larkin, J., 3rd; Boesteanu, A.; Lerman, M. A.; Rankin, A. L. and Caton, A. J. (2006) Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol. Rev., 212, 74-85.
95. Long, M.; Park, S. G.; Strickland, I.; Hayden, M. S. and Ghosh, S. (2009) Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity, 31(6), 921-931.
96. Schmidt-Supprian, M.; Tian, J.; Grant, E. P.; Pasparakis, M.; Maehr, R.; Ovaa, H.; Ploegh, H. L.; Coyle, A. J. and Rajewsky, K. (2004) Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. USA, 101(13), 4566-4571.
97. Koonpaew, S.; Shen, S.; Flowers, L. and Zhang, W. (2006) LAT-mediated signaling in CD4+CD25+ regulatory T cell development. J. Exp. Med., 203(1), 119-129.
98. Gupta, S.; Manicassamy, S.; Vasu, C.; Kumar, A.; Shang, W. and Sun, Z. (2008) Differential requirement of PKC-theta in the development and function of natural regulatory T cells. Mol. Immunol., 46(2), 213-224.
99. Medoff, B. D.; Landry, A. L.; Wittbold, K. A.; Sandall, B. P.; Derby, M. C.; Cao, Z.; Adams, J. C. and Xavier, R. J. (2009) CARMA3 mediates lysophosphatidic acid-stimulated cytokine secretion by bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol., 40(3), 286-294.
100. Shen, S.; Chuck, M. I.; Zhu, M.; Fuller, D. M.; Yang, C. W. and Zhang, W. (2010) The importance of LAT in the activation, homeostasis, and regulatory function of T cells. J. Biol. Chem., 285(46), 35393-35405.
101. Vang, K. B.; Yang, J.; Pagan, A. J.; Li, L. X.; Wang, J.; Green, J. M.; Beg, A. A. and Farrar, M. A. (2010) Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development. J. Immunol., 184(8), 4074-4077.
102. Soligo, M.; Camperio, C.; Caristi, S.; Scotta, C.; Del Porto, P.; Costanzo, A.; Mantel, P. Y.; Schmidt-Weber, C. B. and Piccolella, E. (2011) CD28 costimulation regulates FOXP3 in a RelA/ NF-kappaB-dependent mechanism. Eur. J. Immunol., 2011, 41(2), 503-513.
103. Song, J.; Lei, F. T.; Xiong, X. and Haque, R. (2008) Intra-cellular signals of T cell costimulation. Cell. Mol. Immunol., 5(4), 239-247.
104. Tang, Q.; Henriksen, K. J.; Boden, E. K.; Tooley, A. J.; Ye, J.; Subudhi, S. K.; Zheng, X. X.; Strom, T. B. and Bluestone, J. A. (2003) Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol., 171(7), 3348-3352.
105. Hombach, A. A.; Kofler, D.; Rappl, G. and Abken, H. (2009) Redirecting human CD4+CD25+ regulatory T cells from the peripheral blood with pre-defined target specificity. Gene. Ther., 16(9), 1088-1096.
106. Tai, X.; Cowan, M.; Feigenbaum, L. and Singer, A. (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol., 6(2), 152-162.
107. Guo, F.; Iclozan, C.; Suh, W. K.; Anasetti, C. and Yu, X. Z. (2008) CD28 controls differentiation of regulatory T cells from naive CD4 T cells. J. Immunol., 181(4), 2285-2291.
108. Gherzi, R.; Trabucchi, M.; Ponassi, M.; Ruggiero, T.; Corte, G.; Moroni, C.; Chen, C. Y.; Khabar, K. S.; Andersen, J. S. and Briata, P. (2006) The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol., 5(1), e5.
109. Nazarov-Stoica, C.; Surls, J.; Bona, C.; Casares, S. and Brumeanu, T. D. (2009) CD28 signaling in T regulatory precursors requires p56lck and rafts integrity to stabilize the Foxp3 message. J. Immunol., 182(1), 102-110.
110. Tavano, R.; Gri, G.; Molon, B.; Marinari, B.; Rudd, C. E.; Tuosto, L. and Viola, A. (2004) CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of human T lymphocytes. J. Immunol., 173(9), 5392-5397.
111. Lio, C. W.; Dodson, L. F.; Deppong, C. M.; Hsieh, C. S. and Green, J. M. (2010) CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors. J. Immunol., 184(11), 6007-6013.
112. Semple, K.; Nguyen, A.; Yu, Y.; Wang, H.; Anasetti, C. and Yu, X. Z. (2011) Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling. Blood, 117(11), 3096-3103.
113. So, T. and Croft, M. (2007) Cutting edge: OX40 inhibits TGF-beta-and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells. J. Immunol., 179(3), 1427-1430.
114. Kroemer, A.; Xiao, X.; Vu, M. D.; Gao, W.; Minamimura, K.; Chen, M.; Maki, T. and Li, X. C. (2007) OX40 controls functionally different T cell subsets and their resistance to depletion therapy. J. Immunol., 179(8), 5584-5591.
115. Piconese, S.; Valzasina, B. and Colombo, M. P. (2008) OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J. Exp. Med., 205(4), 825-839.
116. Kitamura, N.; Murata, S.; Ueki, T.; Mekata, E.; Reilly, R. T.; Jaffee, E. M. and Tani, T. (2009) OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity. Int. J. Cancer, 125(3), 630-638.
117. Valzasina, B.; Guiducci, C.; Dislich, H.; Killeen, N.; Weinberg, A. D. and Colombo, M. P. (2005) Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood, 105(7), 2845-2851.
118. Hippen, K. L.; Harker-Murray, P.; Porter, S. B.; Merkel, S. C.; Londer, A.; Taylor, D. K.; Bina, M.; Panoskaltsis-Mortari, A.; Rubinstein, P.; Van Rooijen, N.; Golovina, T. N.; Suhoski, M. M.; Miller, J. S.; Wagner, J. E.; June, C. H.; Riley, J. L. and Blazar, B. R. (2008) Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood, 112(7), 2847-2857.
119. Ruby, C. E.; Yates, M. A.; Hirschhorn-Cymerman, D.; Chlebeck, P.; Wolchok, J. D.; Houghton, A. N.; Offner, H. and Weinberg, A. D. (2009) Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right. J. Immunol., 183(8), 4853-4857.
120. Griseri, T.; Asquith, M.; Thompson, C. and Powrie, F. (2010) OX40 is required for regulatory T cell-mediated control of colitis. J. Exp. Med., 207(4), 699-709.
121. Piconese, S.; Pittoni, P.; Burocchi, A.; Gorzanelli, A.; Care, A.; Tripodo, C. and Colombo, M. P. (2010) A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2. Eur. J. Immunol., 40(10), 2902-2913.
122. Takeda, I.; Ine, S.; Killeen, N.; Ndhlovu, L. C.; Murata, K.; Satomi, S.; Sugamura, K. and Ishii, N. (2004) Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol., 172(6), 3580-3589.
123. Zheng, G.; Wang, B. and Chen, A. (2004) The 4-1BB costi-mulation augments the proliferation of CD4+CD25+ regulatory T cells. J. Immunol., 173(4), 2428-2434.
124. Elpek, K. G.; Yolcu, E. S.; Franke, D. D.; Lacelle, C.; Schabowsky, R. H. and Shirwan, H. (2007) Ex vivo expansion of CD4+CD25+ FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J. Immunol., 179(11), 7295-7304.
125. Choi, B. K.; Bae, J. S.; Choi, E. M.; Kang, W. J.; Sakaguchi, S.; Vinay, D. S. and Kwon, B. S. (2004) 4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells. J. Leukoc. Biol., 75(5), 785-791.
126. Kemper, C.; Chan, A. C.; Green, J. M.; Brett, K. A.; Murphy, K. M. and Atkinson, J. P. (2003) Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature, 421(6921), 388-392.
127. Grossman, W. J.; Verbsky, J. W.; Barchet, W.; Colonna, M.; Atkinson, J. P. and Ley, T. J. (2004) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity, 21(4), 589-601.
128. Grossman, W. J.; Verbsky, J. W.; Tollefsen, B. L.; Kemper, C.; Atkinson, J. P. and Ley, T. J. (2004) Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood, 104(9), 2840-2848.
129. Astier, A. L.; Meiffren, G.; Freeman, S. and Hafler, D. A. (2006) Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest., 116(12), 3252-3257.
130. Krupnick, A. S.; Gelman, A. E.; Barchet, W.; Richardson, S.; Kreisel, F. H.; Turka, L. A.; Colonna, M.; Patterson, G. A. and Kreisel, D. (2005) Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J. Immunol., 175(10), 6265-6270.
131. Kitazawa, Y.; Fujino, M.; Wang, Q.; Kimura, H.; Azuma, M.; Kubo, M.; Abe, R. and Li, X. K. (2007) Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Transplantation, 83(6), 774-782.
132. Francisco, L. M.; Salinas, V. H.; Brown, K. E.; Vanguri, V. K.; Freeman, G. J.; Kuchroo, V. K. and Sharpe, A. H. (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med., 206(13), 3015-3029.
133. Francisco, L. M.; Sage, P. T. and Sharpe, A. H. (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev., 236, 219-242.
134. Mantel, P. Y.; Ouaked, N.; Ruckert, B.; Karagiannidis, C.; Welz, R.; Blaser, K. and Schmidt-Weber, C. B. (2006) Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol., 176(6), 3593-3602.
135. Kim, H. P. and Leonard, W. J. (2007) CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med., 204(7), 1543-1551.
136. Hogan, P. G.; Chen, L.; Nardone, J. and Rao, A. (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev., 17(18), 2205-2232.
137. van Wijnen, A. J.; Stein, G. S.; Gergen, J. P.; Groner, Y.; Hiebert, S. W.; Ito, Y.; Liu, P.; Neil, J. C.; Ohki, M. and Speck, N. (2004)Nomenclature for Runt-related (RUNX) proteins. Oncogene, 23(24), 4209-4210.
138. Bruno, L.; Mazzarella, L.; Hoogenkamp, M.; Hertweck, A.; Cobb, B. S.; Sauer, S.; Hadjur, S.; Leleu, M.; Naoe, Y.; Telfer, J. C.; Bonifer, C.; Taniuchi, I. and Fisher, A. G and Merkenschlager, M. (2009) Runx proteins regulate Foxp3 expression. J. Exp. Med., 206(11), 2329-2337.
139. Kitoh, A.; Ono, M.; Naoe, Y.; Ohkura, N.; Yamaguchi, T.; Yaguchi, H.; Kitabayashi, I.; Tsukada, T.; Nomura, T.; Miyachi, Y.; Taniuchi, I. and Sakaguchi, S. (2009) Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity, 31(4), 609-620.
140. Klunker, S.; Chong, M. M.; Mantel, P. Y.; Palomares, O.; Bassin, C.; Ziegler, M.; Ruckert, B.; Meiler, F.; Akdis, M.; Littman, D. R. and Akdis, C. A. (2009) Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J. Exp. Med., 206(12), 2701-2715.
141. Rudra, D.; Egawa, T.; Chong, M. M.; Treuting, P.; Littman, D. R. and Rudensky, A. Y. (2009) Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol., 10(11), 1170-1177.
142. Ouyang, W.; Beckett, O.; Flavell, R. A. and Li, M. O. (2009) An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity, 30(3), 358-371.
143. Gubbels Bupp, M. R.; Edwards, B.; Guo, C.; Wei, D.; Chen, G.; Wong, B.; Masteller, E. and Peng, S. L. (2009) T cells require Foxo1 to populate the peripheral lymphoid organs. Eur. J. Immunol., 39(11), 2991-2999.
144. Harada, Y.; Elly, C.; Ying, G.; Paik, J. H.; DePinho, R. A. and Liu, Y. C. (2010) Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med., 207(7), 1381-1391.
145. Kerdiles, Y. M.; Stone, E. L.; Beisner, D. L.; McGargill, M. A.; Ch'en, I. L.; Stockmann, C.; Katayama, C. D. and Hedrick, S. M. (2010) Foxo transcription factors control regulatory T cell development and function. Immunity, 33(6), 890-904.
146. Sharpe, A. H. and Abbas, A. K. (2006) T-cell costimulation--biology, therapeutic potential, and challenges. N. Engl. J. Med., 355(10), 973-975.
147. Zheng, S. G.; Wang, J. H.; Stohl, W.; Kim, K. S.; Gray, J. D. and Horwitz, D. A. (2006) TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol., 176(6), 3321-3329.
148. Akbari, O.; Freeman, G. J.; Meyer, E. H.; Greenfield, E. A.; Chang, T. T.; Sharpe, A. H.; Berry, G.; DeKruyff, R. H. and Umetsu, D. T. (2002) Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med., 8(9), 1024-1032.
149. Zhang, P.; Gao, F.; Wang, Q.; Wang, X.; Zhu, F.; Ma, C.; Sun, W. and Zhang, L. (2007) Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression. Scand. J. Immunol., 66(4), 435-440.
150. Bollyky, P. L.; Falk, B. A.; Long, S. A.; Preisinger, A.; Braun, K. R.; Wu, R. P.; Evanko, S. P.; Buckner, J. H.; Wight, T. N. and Nepom, G. T. (2009) CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J. Immunol., 183(4), 2232-2241.
151. Xu, Y. Q.; Gao, Y. D.; Yang, J. and Guo, W. (2010) A defect of CD4+CD25+ regulatory T cells in inducing interleukin-10 production from CD4+ T cells under CD46 costimulation in asthma patients. J. Asthma, 47(4), 367-373.